z-logo
open-access-imgOpen Access
The COVID-19 viral 3a protein forms a potassium channel that can be inhibited by antiarrhythmic drugs
Author(s) -
Felix Wiedmann,
Emika Boondej,
Megan L. Stanifer,
A Paasche,
Manuel Kraft,
Timon Seeger,
Ulrike Uhrig,
Norbert Frey,
Steeve Boulant,
Constanze Schmidt
Publication year - 2022
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/euac053.604
Subject(s) - medicine , potassium channel , pharmacology , induced pluripotent stem cell , potassium channel blocker , virology , cardiology , microbiology and biotechnology , gene , biology , genetics , embryonic stem cell

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom